Protagonist Therapeutics
Price & Volume
Stats
See more52W Range | $44.04-$107.84 |
Market Cap | $6.5B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $74M |
Revenue Growth (YoY) | 99% |
Gross Profit (12 Mos) | $74M |
Diluted EPS | -$1.81 |
News
See moreYahoo Finance • 20 days ago
Protagonist Therapeutics Inc. (PTGX): Billionaire Joe Edelman Likes This Stock
Yahoo Finance • 25 days ago
Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight
Yahoo Finance • 2 months ago
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Yahoo Finance • 2 months ago
Do Protagonist Therapeutics’ (PTGX) Derisked Drugs Have Blockbuster Potential?
About
CEO | Dr. Dinesh V. Patel Ph.D. |
CFO | Mr. Asif Ali |
Address | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 131 |